Evidence map›Paper›PMID 34206245›Full record

ReviewMembranes2021

Antiviral Nanomaterials for Designing Mixed Matrix Membranes.

Abayomi Babatunde Alayande, Yesol Kang, Jaewon Jang, Hobin Jee, Yong-Gu Lee, In S Kim, Euntae Yang

Abstract readReview
In one paragraph

Review in Membranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Strategies for safe management of hospital wastewater during the COVID-19 pandemic.International journal of environmental science and technology : IJEST · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abayomi Babatunde AlayandeSchool of Civil, Environmental and Architectural Engineering, Korea University, Seoul 02841, Korea.ORCID 0000-0001-6159-0073
Yesol KangSchool of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID 0000-0001-6742-1780
Jaewon JangSchool of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID 0000-0002-8128-3414
Hobin JeeDepartment of Marine Environmental Engineering, Gyeongsang National University, Tongyeong-si 53064, Korea.
Yong-Gu LeeDepartment of Environmental Engineering, College of Engineering, Kangwon National University, Chuncheon-si 24341, Korea.ORCID 0000-0002-1519-6136
In S KimSchool of Earth Sciences and Environmental Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Euntae YangDepartment of Marine Environmental Engineering, Gyeongsang National University, Tongyeong-si 53064, Korea.ORCID 0000-0001-5139-9910

Funding

National Research Foundation of Korea 2020R1C1C101317212
6 · The paper itself

Abstract

Membranes are helpful tools to prevent airborne and waterborne pathogenic microorganisms, including viruses and bacteria. A membrane filter can physically separate pathogens from air or water. Moreover, incorporating antiviral and antibacterial nanoparticles into the matrix of membrane filters can render composite structures capable of killing pathogenic viruses and bacteria. Such membranes incorporated with antiviral and antibacterial nanoparticles have a great potential for being applied in various application scenarios. Therefore, in this perspective article, we attempt to explore the fundamental mechanisms and recent progress of designing antiviral membrane filters, challenges to be addressed, and outlook.

Indexed as

antiviralmixed matrix membranenanomaterialvirucidal

Identifiers

PMID34206245
PMCPMC8303748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.